Showing results (181-190 of 496) with videos related to

Sort By:
Pageof 50
Obesity (Silver Spring, Md.)|September 20, 2014
Identification of two novel loss-of-function SIM1 mutations in two overweight children with developmental delayLouise Montagne, Anne Raimondo, Bruno Delobel, et al.
Cells|March 29, 2023
High-Throughput Quantitative Screening of Glucose-Stimulated Insulin Secretion and Insulin Content Using Automated MALDI-TOF Mass SpectrometryClément Philippe Delannoy, Egon Heuson, Adrien Herledan, et al.
Diabetes|March 29, 2006
The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) studyRiphed Jaziri, Stephane Lobbens, Roberte Aubert, et al.
Nature Genetics|July 16, 2013
Association between large detectable clonal mosaicism and type 2 diabetes with vascular complicationsAmélie Bonnefond, Boris Skrobek, Stéphane Lobbens, et al.
The Journal of Biological Chemistry|July 25, 2003
Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectinHironori Waki, Toshimasa Yamauchi, Junji Kamon, et al.
Diabetes|January 31, 2006
ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesityNabila Bouatia-Naji, David Meyre, Stéphane Lobbens, et al.
Diabetes|December 24, 2004
Common Polymorphisms in the Adiponectin Gene ACDC Are Not Associated With Diabetes in Pima IndiansBarbora Vozarova de Courten, Robert L Hanson, Tohru Funahashi, et al.
Diabetologia|August 15, 2013
Parental history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident hypertension. Data from the DESIR and RISC cohortsFabrice Bonnet, Ronan Roussel, Andrea Natali, et al.
Science (New York, N.Y.)|October 15, 2016
Detection of human adaptation during the past 2000 yearsYair Field, Evan A Boyle, Natalie Telis, et al.
Plos One|April 9, 2014
Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese miceKassem Makki, Solenne Taront, Olivier Molendi-Coste, et al.
Pageof 50